rtx1 users present new clinical data at ARVO 2024

At ARVO 2024, users of rtx1 AO cameras will introduce new biomarkers for assessing photoreceptors, RPE cells, pigment redistibution and neurovascular coupling in clinical studies. 11 posters and presentations report new findings in non-exudative AMD, inherited retinal diseases, retinal detachment, and diabetic retinopathy.

Sunday, May 5

  • Poster B0547:
    Adaptive Optics Imaging in Retinal Detachment: A Retrospective Analysis.
    Andrew Mihalache (Canada)
  • Poster B0644:
    Automated segmentation of cone photoreceptors in AO-FIO: a multi-center study.
    Danilo Andrade De Jesus (Erasmus MC, Netherlands)

Monday, May 6

  • Presentation in session ‘Progress on adaptive optics imaging’:
    Comparing two adaptive optics imaging methods of retinal pigmented epithelial (RPE) cells.
    Kiyoko Gocho (Quinze-Vingts National Eye Hospital & INSERM, France)
  • Poster A0159:
    Adaptive optics in patients with early-onset macular degeneration.
    Mahfam Shahabi (Radboud UMC, Netherlands)
  • Poster A0167:
    Hyperpigmented spots during enlargement of geographic atrophy.
    Michel Paques (Quinze-Vingts National Eye Hospital, France)

Tuesday, May 7

Thursday, May 9

  • Poster B0530:
    Adaptive optics (AO) retinal imaging delineates retinal changes in patients at all ETDRS stages of diabetic macular ischemia, undetectable by other structural and functional imaging in mild to moderate ischemia.
    Nick Muthiah (Moorfields Eye Hospital, UK)
  • Poster B0877:
    Phenotypic Variability and Evolution of MFSD8-related Retinal Disease.
    Manon Van Haute (Ghent University Hospital, Belgium)


Schedule your in-person meeting with Imagine Eyes at ARVO 2024